- Home
- BEEP vs FENC Comparison
BEEP vs FENC Comparison
Compare BEEP & FENC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BEEP | FENC |
|---|---|---|
| Founded | 2015 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Blank Checks | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 129.4M | 258.5M |
| IPO Year | N/A | 2001 |
Fundamental Metrics
Financial Performance| Metric | BEEP | FENC |
|---|---|---|
| Price | $3.28 | $7.62 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 2 |
| Target Price | $6.75 | ★ $13.50 |
| AVG Volume (30 Days) | 64.1K | ★ 219.0K |
| Earning Date | 11-10-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $35,470,000.00 | ★ $38,790,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $2.97 | $75.22 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.50 | $4.68 |
| 52 Week High | $4.86 | $9.92 |
Technical Indicators
Market Signals| Indicator | BEEP | FENC |
|---|---|---|
| Relative Strength Index (RSI) | 59.38 | 42.20 |
| Support Level | $2.73 | $7.35 |
| Resistance Level | $2.92 | $7.74 |
| Average True Range (ATR) | 0.23 | 0.36 |
| MACD | 0.05 | -0.01 |
| Stochastic Oscillator | 97.50 | 20.00 |
Price Performance
Historical ComparisonAbout BEEP Mobile Infrastructure Corporation
Mobile Infrastructure Corp focuses on acquiring, owning, and leasing parking facilities and related infrastructure, including parking lots, parking garages and other parking structures throughout the United States. It operates in a single reportable segment: parking. The parking segment derives revenue from managed property revenue and rental income at parking facilities. The company provide access to property and space for the parker's vehicle and charges fees that vary based on the level of usage. The company derives all of its revenue domestically.
About FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.